"Wholesalers have been fulfilling orders from pharmacies at very high levels," CEO David Ricks told analysts
Targets: Targets: The additional glucagon activity may help increase energy expenditure and support greater fat loss, which may explain the superior weight loss outcomes seen in clinical trials
Diabetes, Obesity and Metabolism, 24(1)
41 Healthcare disparities exist, as Black and Hispanic patients are significantly less likely to be prescribed GLP-1RA compared to White and non-Hispanic patients
However, it is still a Schedule II controlled substance with a significant risk of dependence and addiction, especially at high doses or when misused
RTD shakes address this challenge by offering a quick, nutritionally balanced option that requires no preparation and can be consumed anytime, anywhere